|
Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)
|
Richard Lafayette
|
Recruiting
|
|
Transformative Research in Diabetic Nephropathy
|
Richard Lafayette
|
Recruiting
|
|
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
|
Richard Lafayette
|
Recruiting
|
|
Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
|
Richard Lafayette
|
Recruiting
|
|
Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy
|
Richard Lafayette
|
Recruiting
|
|
Sit Less, Interact and Move More (SLIMM) 2 Study
|
Glenn M. Chertow
|
Recruiting
|
|
Nephrotic Syndrome Study Network
|
Richard Lafayette
|
Recruiting
|
|
Improving Medical Decision Making for Older Patients With End Stage Renal Disease
|
Manjula Kurella Tamura
|
Recruiting
|
|
FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
|
Jaimie Henderson, MD
Vivek P. Buch, MD
Richard Lafayette
|
Recruiting
|
|
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
|
Tammy Lisa Sirich
|
Recruiting
|
|
Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis
|
Timothy Meyer
|
Recruiting
|
|
Efficacy of Diuretics in Kidney Disease
|
Tammy Lisa Sirich
|
Recruiting
|
|
Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.
|
Stephan Busque
Robert Lowsky
Marc L. Melcher
Richard Hoppe
John Scandling
Judith Shizuru
|
Recruiting
|
|
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
|
Tara I. Chang
|
Recruiting
|
|
Belimumab in Remission of VASculitis
|
Richard Lafayette
|
Recruiting
|
|
A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)
|
Richard Lafayette
|
Recruiting
|
|
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
|
Richard Lafayette
|
Recruiting
|
|
A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy
|
Richard Lafayette
|
Recruiting
|
|
Atacicept in Subjects With IgA Nephropathy
|
Richard Lafayette
|
Recruiting
|
|
A Study of Felzartamab in Participants With Lupus Nephritis
|
Richard Lafayette
|
Recruiting
|
|
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
|
Richard Lafayette
|
Recruiting
|